AQR Capital Management’s Beam Therapeutics BEAM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $432K | Buy |
+25,421
| New | +$432K | ﹤0.01% | 2696 |
|
|
2024
Q4 | – | Sell |
-8,842
| Closed | -$217K | – | 2876 |
|
|
2024
Q3 | $217K | Sell |
8,842
-169
| -2% | -$4.14K | ﹤0.01% | 2528 |
|
|
2024
Q2 | $211K | Buy |
9,011
+2,487
| +38% | +$58.3K | ﹤0.01% | 2406 |
|
|
2024
Q1 | $216K | Buy |
+6,524
| New | +$216K | ﹤0.01% | 2237 |
|
|
2023
Q1 | – | Sell |
-9,599
| Closed | -$375K | – | 2166 |
|
|
2022
Q4 | $375K | Sell |
9,599
-42
| -0.4% | -$1.64K | ﹤0.01% | 1913 |
|
|
2022
Q3 | $459K | Buy |
+9,641
| New | +$459K | ﹤0.01% | 1820 |
|
|
2022
Q1 | – | Sell |
-7,424
| Closed | -$592K | – | 2218 |
|
|
2021
Q4 | $592K | Sell |
7,424
-15,304
| -67% | -$1.22M | ﹤0.01% | 1777 |
|
|
2021
Q3 | $1.98M | Buy |
22,728
+4,228
| +23% | +$368K | ﹤0.01% | 1155 |
|
|
2021
Q2 | $2.38M | Buy |
18,500
+7,979
| +76% | +$1.03M | ﹤0.01% | 1131 |
|
|
2021
Q1 | $842K | Buy |
10,521
+2,122
| +25% | +$170K | ﹤0.01% | 1626 |
|
|
2020
Q4 | $686K | Buy |
+8,399
| New | +$686K | ﹤0.01% | 1664 |
|